Trial Profile
Pivotal US trial of the folate-containing oral contraceptive SAFRYL
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Dec 2010
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/drospirenone/levomefolic acid (Primary) ; Drospirenone/ethinylestradiol
- Indications Pregnancy
- Focus Pharmacodynamics; Registrational
- Sponsors Bayer
- 17 Dec 2010 Based on the results of this pivotal study, the oral contraceptive ethinylestradiol/drospirenone/levomefolic-acid (Safyral) has been approved by the US FDA, according to a Bayer media release.
- 16 Dec 2010 New trial record